Cynosure gets FDA clearance to market laser system that removes tattoos


Cynosure Inc., a Westford-based company specializing in laser- and light-based treatments for aesthetic applications, said Tuesday that it has received regulatory clearance to market a laser work station designed for the removal of tattoos and benign pigmented lesions.

Getting a 510(k) clearance from the Food and Drug Administration clears the way for Cynosure to begin selling its PicoSure laser work stations to aesthetic dermatologists and plastic surgeons in early 2013, the company said.

“With data indicating that an estimated 20 percent of the 45 million Americans with at least one tattoo want to have it removed, the FDA clearance of PicoSure creates a first-mover advantage for Cynosure to treat a large and vastly underserved market,” president and chief executive Michael Davin said in a statement.

Chris Reidy can be reached at
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of